These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32244216)

  • 1. Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance.
    Carrión-Penagos J; Zeineddine HA; Polster SP; Girard R; Lyne SB; Koskimäki J; Romanos S; Srinath A; Zhang D; Cao Y; Stadnik A; Piedad K; Shenkar R; Awad IA
    J Neurosurg; 2021 Mar; 134(3):1147-1154. PubMed ID: 32244216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of brainstem cavernous malformations: prospective hemorrhage rate and adverse factors in a consecutive prospective cohort.
    Li D; Wu ZY; Liu PP; Ma JP; Huo XL; Wang L; Zhang LW; Wu Z; Zhang JT
    J Neurosurg; 2021 Mar; 134(3):917-928. PubMed ID: 32168479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage.
    Zeineddine HA; Girard R; Cao Y; Hobson N; Fam MD; Stadnik A; Tan H; Shen J; Chaudagar K; Shenkar R; Thompson RE; McBee N; Hanley D; Carroll T; Christoforidis GA; Awad IA
    J Magn Reson Imaging; 2018 Apr; 47(4):1133-1138. PubMed ID: 28791783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Susceptibility Mapping in Cerebral Cavernous Malformations: Clinical Correlations.
    Tan H; Zhang L; Mikati AG; Girard R; Khanna O; Fam MD; Liu T; Wang Y; Edelman RR; Christoforidis G; Awad IA
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1209-15. PubMed ID: 26965464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations.
    Girard R; Fam MD; Zeineddine HA; Tan H; Mikati AG; Shi C; Jesselson M; Shenkar R; Wu M; Cao Y; Hobson N; Larsson HBW; Christoforidis GA; Awad IA
    J Neurosurg; 2017 Jul; 127(1):102-110. PubMed ID: 27494817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness Project.
    Kim H; Flemming KD; Nelson JA; Lui A; Majersik JJ; Cruz MD; Zabramski J; Trevizo O; Lanzino G; Zafar A; Torbey M; Mabray MC; Robinson M; Narvid J; Lupo J; Thompson RE; Hanley DF; McBee N; Treine K; Ostapkovich N; Stadnik A; Piedad K; Hobson N; Carroll T; Shkoukani A; Carrión-Penagos J; Mendoza-Puccini C; Koenig JI; Awad I
    Stroke; 2021 Dec; 52(12):3829-3838. PubMed ID: 34525838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral Venous Malformations in a Chinese Population: Clinical Manifestations, Radiological Characteristics, and Long-Term Prognosis.
    Kang K; Ju Y; Wang D; Li H; Sun L; Ma K; Zhao X; Lu J
    World Neurosurg; 2018 Dec; 120():e472-e479. PubMed ID: 30149153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliable? The Value of Early Postoperative Magnetic Resonance Imaging after Cerebral Cavernous Malformation Surgery.
    Chen B; Göricke S; Wrede K; Jabbarli R; Wälchli T; Jägersberg M; Sure U; Dammann P
    World Neurosurg; 2017 Jul; 103():138-144. PubMed ID: 28391022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical course of untreated thalamic cavernous malformations: hemorrhage risk and neurological outcomes.
    Tian KB; Zheng JJ; Ma JP; Hao SY; Wang L; Zhang LW; Wu Z; Zhang JT; Li D
    J Neurosurg; 2017 Sep; 127(3):480-491. PubMed ID: 27834594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth.
    Girard R; Zeineddine HA; Koskimäki J; Fam MD; Cao Y; Shi C; Moore T; Lightle R; Stadnik A; Chaudagar K; Polster S; Shenkar R; Duggan R; Leclerc D; Whitehead KJ; Li DY; Awad IA
    Circ Res; 2018 Jun; 122(12):1716-1721. PubMed ID: 29720384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of familial and sporadic pediatric cerebral cavernous malformations and outcomes.
    Jaman E; Abdallah HM; Zhang X; Greene S
    J Neurosurg Pediatr; 2023 Oct; 32(4):506-513. PubMed ID: 37503918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling.
    Hage S; Kinkade S; Girard R; Flemming KD; Kim H; Torbey MT; Huang J; Huston J; Shu Y; Selwyn RG; Hart BL; Mabray MC; Feghali J; Sair HI; Narvid J; Lupo JM; Lee J; Stadnik A; Alcazar-Felix RJ; Shenkar R; Hobson N; DeBiasse D; Lane K; McBee NA; Treine K; Ostapkovich N; Wang Y; Thompson RE; Koenig JI; Carroll T; Hanley DF; Awad IA
    Stroke; 2024 Jan; 55(1):31-39. PubMed ID: 38134265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Cerebral Cavernous Malformations.
    Paddock M; Lanham S; Gill K; Sinha S; Connolly DJA
    Pediatr Neurol; 2021 Mar; 116():74-83. PubMed ID: 33494000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Management and Long-Term Seizure Outcome After Surgery for Temporal Lobe Epilepsy Associated with Cerebral Cavernous Malformations.
    Yang PF; Pei JS; Jia YZ; Lin Q; Xiao H; Zhang TT; Zhong ZH
    World Neurosurg; 2018 Feb; 110():e659-e670. PubMed ID: 29175574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial Hemorrhage Rate and Lesion Burden in Patients With Familial Cerebral Cavernous Malformation.
    Weinsheimer S; Nelson J; Abla AA; Ko NU; Tsang C; Okoye O; Zabramski JM; Akers A; Zafar A; Mabray MC; Hart BL; Morrison L; McCulloch CE; Kim H;
    J Am Heart Assoc; 2023 Feb; 12(3):e027572. PubMed ID: 36695309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part I: Event Rates and Clinical Outcome.
    Flemming KD; Kim H; Hage S; Mandrekar J; Kinkade S; Girard R; Torbey M; Huang J; Huston J; Shu Y; Lanzino G; Selwyn R; Hart B; Mabray M; Feghali J; Sair HI; Narvid J; Lupo JM; Lee J; Stadnik A; Alcazar-Felix RJ; Shenkar R; Lane K; McBee N; Treine K; Ostapkovich N; Wang Y; Thompson R; Koenig JI; Carroll T; Hanley D; Awad I
    Stroke; 2024 Jan; 55(1):22-30. PubMed ID: 38134268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cranial Cavernous Malformations: Natural History and Treatment.
    Stapleton CJ; Barker FG
    Stroke; 2018 Apr; 49(4):1029-1035. PubMed ID: 29535273
    [No Abstract]   [Full Text] [Related]  

  • 18. Natural history of familial cerebral cavernous malformation syndrome in children: a multicenter cohort study.
    Geraldo AF; Alves CAPF; Luis A; Tortora D; Guimarães J; Abreu D; Reimão S; Pavanello M; de Marco P; Scala M; Capra V; Vaz R; Rossi A; Schwartz ES; Mankad K; Severino M
    Neuroradiology; 2023 Feb; 65(2):401-414. PubMed ID: 36198887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical features and treatment of cerebral cavernous angiomas in children].
    Xie J; Ma Z; Luo S
    Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(6):407-9. PubMed ID: 11953209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemorrhage risk, surgical management, and functional outcome of brainstem cavernous malformations.
    Li D; Yang Y; Hao SY; Wang L; Tang J; Xiao XR; Zhou H; Jia GJ; Wu Z; Zhang LW; Zhang JT
    J Neurosurg; 2013 Oct; 119(4):996-1008. PubMed ID: 23952884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.